Skip to main content

Table 5 Application of immune cells DDS applied in PD

From: Immune cells: potential carriers or agents for drug delivery to the central nervous system

Immune cells

Components

Loaded drugs/nanoparticles

Methods

Model

Functions

References

Macrophage

Cell

Catalase/PEI-PEG complexes

Trojan horse

MPTP-intoxicated mice

BBB model in vitro

Target affected brain subregions in models of PD and transport the loaded drug from macrophages to endothelial, neuronal, and glial target cells

Reduce oxidative stress

Reductions microglial activation and astrocytosis

Increase survival of dopaminergic neurons and nigrostriatal NAA levels

[40, 207,208,209]

 

Cell

Catalase pDNA

Gene transfection

6-OHDA or LPS-induced brain inflammation model

Target BBB and transfer the loaded drug to neural cells

Reduce inflammation

Increase neuroprotection

Improve motor functions

[210]

 

Cell

GDNF

Gene transfection

MPTP-intoxicated mice

MitoPark mouse

6-OHDA-intoxicated mice

Transgenic Parkin Q311X(A) mice

Ameliorate neurodegeneration and neuroinflammation

Stimulate axon regeneration

Diminish alpha-synuclein aggregation

Increase survival of dopaminergic neurons

Improve motor and non-motor dysfunction

[211,212,213,214,215]

Bone marrow-derived-microglia

Cell

Neurturin

Lentiviral transduction

MPTP-intoxicated mice

Protect dopaminergic neurons

Ameliorate neurodegeneration and dopaminergic injury

Improve motor dysfunction

[217]

Macrophage

Exosomes

GDNF

Gene transfection and differential centrifugation

Transgenic Parkin Q311(X)A mice

Improve mobility

Increase neuronal survival

Decrease neuroinflammation

[216]

Macrophage

Exosomes

Catalase

Differential centrifugation and filtration; incubation at RT with or without saponin

Freeze/thaw cycles technique

Sonication

Extrusion

6-OHDA-intoxicated mice

Target neuronal cells

Protect substantia nigra neurons against oxidative stress

[218]

Macrophage

Nanovesicles

Curcumin

Recycled exclusion and sonication

MPP+-induced neuronal degeneration model

Target BBB and neurons

Ameliorate neurodegeneration

[219]

  1. 6-OHDA 6-hydroxidophamine, BBB blood–brain barrier, GDNF glial cell line-derived neurotrophic factor, LPS lipopolysaccharides, MPP+ 1-methyl-4-phenylpyridinium, MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, NAA N-Acetyl-L-aspartic acid, PD Parkinson’s disease, pDNA plasmid DNA, PEI-PEG polyethyleneimine-poly (ethylene glycol), RT room temperature